Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quest Patent Research (QPRC) Cash & Equivalents (2016 - 2025)

Quest Patent Research's Cash & Equivalents history spans 17 years, with the latest figure at $175141.0 for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 28.04% year-over-year to $175141.0; the TTM value through Sep 2025 reached $175141.0, up 28.04%, while the annual FY2024 figure was $482023.0, 14.46% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $175141.0 at Quest Patent Research, down from $254659.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $770696.0 in Q1 2024 and bottomed at $47822.0 in Q1 2025.
  • The 5-year median for Cash & Equivalents is $213880.0 (2021), against an average of $260532.4.
  • The largest annual shift saw Cash & Equivalents skyrocketed 704.9% in 2023 before it plummeted 93.79% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $264840.0 in 2021, then crashed by 65.79% to $90601.0 in 2022, then surged by 521.94% to $563484.0 in 2023, then fell by 14.46% to $482023.0 in 2024, then tumbled by 63.67% to $175141.0 in 2025.
  • Per Business Quant, the three most recent readings for QPRC's Cash & Equivalents are $175141.0 (Q3 2025), $254659.0 (Q2 2025), and $47822.0 (Q1 2025).